Latest Partnerships And Collaborations News

Lithium Universe advances its U.S. solar panel recycling strategy following silver’s historic classification as a Critical Metal, positioning itself to tap into soaring demand and a growing PV waste stream.

Caravel Minerals has signed a non-binding MOU with Adani’s Kutch Copper to jointly advance the Caravel Copper Project toward a 2026 Final Investment Decision, exploring funding and offtake agreements.

Battery Age Minerals Limited (BM8) is accelerating exploration across its diversified critical metals projects spanning Europe, North America, and South America, positioning itself as a key player in the global supply of germanium, gallium, lithium, gold, and silver.

Kelsian Group reported steady FY25 financial results with a 9.5% revenue increase and reaffirmed FY26 EBITDA guidance, while progressing the strategic divestment of its tourism assets to sharpen focus on core transport services.

Sunrise Energy Metals has secured a strategic partnership with Lockheed Martin, granting the defense giant an option to purchase a quarter of scandium production from the Syerston Project over five years, aiming to boost scandium adoption in aerospace and defense.

Audeara Ltd has reported a remarkable 111% revenue increase in Q1 FY26, driven by strong growth in its technology division and key international partnerships in China and Japan. The company is advancing towards cashflow breakeven with improved cash management and expanding global reach.

ASM Limited has raised A$55 million to accelerate production capacity at its Korean Metals Plant and expand its footprint in the rare earths sector, responding to growing global demand and geopolitical supply chain pressures.

ABx Group’s subsidiary ABx3 has received a $2.7 million investment from Good Importing International, granting GII 70% ownership to develop the Sunrise Bauxite Project in Queensland. This funding kickstarts a 12–24 month program targeting regulatory approvals and mine planning, with further investment options on the horizon.

Optiscan Imaging Ltd has launched a fully underwritten $17.75 million entitlement offer to fund clinical trials and regulatory clearances for its medical devices, marking a pivotal step in its transition to a commercial medical device manufacturer.

Rhythm Biosciences has completed critical validation of its ColoSTAT colorectal cancer assay and submitted it for ISO15189 accreditation, paving the way for commercialisation. The test demonstrated strong clinical performance, highlighting its potential as a non-invasive diagnostic tool.

Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.

WOTSO’s FY25 results reveal a robust 14% increase in underlying EBITDA, driven by its expanding flexible workspace portfolio now spanning 31 locations. Strategic investments and partnerships underpin a confident outlook toward $58 million revenue by FY30.